Solving Compliance Changes in the Pharmaceutical Industry
The Foreign Corrupt Practices Act (FCPA) and the Physician Payment Sunshine Act (Sunshine Act) create an enourmous compliance burden and expose pharamaceutical companies to financial risk. The most common risks for non-compliance include issues with integrating data on internal and 3rd party systems. 60% of the companies interviewed use manual paper-based systems for interacting with third parties. This greatly increases the risk for potential fraud.
Pharmaceutical companies have the need to:
Automate end-to-end business processes
Optimize data quality, compliance, collaboration and traceability
Leverage mobile, social and cloud technologies
Quickly generate reports to detect fraud potential
Appian BPM Software can be used to create mission critical applications that solve the compliance challenges that Pharmaceutical companies face. Learn more about how BPM for Pharmaceuticals helps relieve the burdens of onerous industry regulatory compliance challenges by visiting http://www.appian.com